published_or_final_version / Biochemistry / Master / Master of Philosophy

published_or_final_version / Paediatrics / Master / Master of Philosophy

published_or_final_version / Zoology / Master / Master of Philosophy

eneurin C-terminal associated peptides (TCAPs) are a novel family of peptides encoded on the last exon of the teneurin genes. The predicted peptide sequences are highly conserved across metazoans and possess the structural hallmarks of a cleavable bioactive peptide that are 40 or 41 amino acid residues. One of the peptides in the family, TCAP-1, is a potent regulator of neurite outgrowth and dendritic spine density in the hippocampus and inhibits corticotropin-releasing factor (CRF)-associated stress-induced and cocaine-seeking behaviours. The effects of TCAP-1 are long lasting, suggesting that TCAP-1 plays a significant role in the regulation of cell-to-cell communication and cellular plasticity. Moreover, TCAP-1 regulates cellular energy, metabolism and cell survival and may, therefore, possess functional attributes outside of the CNS. However, the molecular mechanisms associated with TCAP-1-mediated trophic effects are not known. My research was aimed to 1) determine whether TCAP-1 exerts its effects as part of a direct teneurin-1 function, whereby TCAP-1 represents a functional region of the large teneurin-1 protein, or if it has an independent role, either as a splice variant or post-translational proteolytic cleavage product of teneurin-1; 2) map the distribution of TCAP-1-immunoreactivity and TCAP-1 binding sites in mouse; 3) elucidate the molecular mechanism by which TCAP-1 regulates cytoskeletal dynamics; and 4) investigate a role for TCAP-1 in male reproduction. My research establishes that the C-terminal region of teneurin-1, corresponding to TCAP-1, can be both structurally and functionally independent from teneurin-1 in both the brain and testis of the adult mouse. Furthermore, I provide novel evidence that functionally links the teneurin-TCAP-1 system with the dystroglycan complex and provide new insight into the molecular and signaling mechanisms by which TCAP-1 regulates cytoskeletal dynamics. These studies implicate the teneurins in a broader range of neuroendocrine and trophic functions than previously thought and furthers our understanding of the mechanisms associated with TCAP-1-mediated function in the body.

eneurin C-terminal associated peptides (TCAPs) are a novel family of peptides encoded on the last exon of the teneurin genes. The predicted peptide sequences are highly conserved across metazoans and possess the structural hallmarks of a cleavable bioactive peptide that are 40 or 41 amino acid residues. One of the peptides in the family, TCAP-1, is a potent regulator of neurite outgrowth and dendritic spine density in the hippocampus and inhibits corticotropin-releasing factor (CRF)-associated stress-induced and cocaine-seeking behaviours. The effects of TCAP-1 are long lasting, suggesting that TCAP-1 plays a significant role in the regulation of cell-to-cell communication and cellular plasticity. Moreover, TCAP-1 regulates cellular energy, metabolism and cell survival and may, therefore, possess functional attributes outside of the CNS. However, the molecular mechanisms associated with TCAP-1-mediated trophic effects are not known. My research was aimed to 1) determine whether TCAP-1 exerts its effects as part of a direct teneurin-1 function, whereby TCAP-1 represents a functional region of the large teneurin-1 protein, or if it has an independent role, either as a splice variant or post-translational proteolytic cleavage product of teneurin-1; 2) map the distribution of TCAP-1-immunoreactivity and TCAP-1 binding sites in mouse; 3) elucidate the molecular mechanism by which TCAP-1 regulates cytoskeletal dynamics; and 4) investigate a role for TCAP-1 in male reproduction. My research establishes that the C-terminal region of teneurin-1, corresponding to TCAP-1, can be both structurally and functionally independent from teneurin-1 in both the brain and testis of the adult mouse. Furthermore, I provide novel evidence that functionally links the teneurin-TCAP-1 system with the dystroglycan complex and provide new insight into the molecular and signaling mechanisms by which TCAP-1 regulates cytoskeletal dynamics. These studies implicate the teneurins in a broader range of neuroendocrine and trophic functions than previously thought and furthers our understanding of the mechanisms associated with TCAP-1-mediated function in the body.

No description available.

This study was undertaken to characterize the nod and sdh operons of Bradyrhizobium japonicum and Sinorhizobium meliloti. Ten putative B. japonicum mutants with altered nod gene induction characteristics were isolated by screening mutants for genistein-independent nod gene expression. The mutants were found to have higher nodY expression than the wild-type in the presence of genistein. The increased sensitivity of all mutants to genistein was more apparent under suboptimal inducer concentration (0.1muM) and/or temperature (15°C). The expression of nodY gene induction was determined for five strains (Bj30050, 53, 56, 57, 58) under different temperature and inducer conditions. These five strains were also found to produce more lipochitooligosaccharide than the wild-type, at both 25°C and 15°C. Three of the ten mutant strains (including Bj30056 and 57) were unable to fix nitrogen with soybeans grown at optimal temperatures. Based on nodY gene expression and symbiotic phenotype the B. japonicum mutants were classified into three groups. / A molecular genetic approach was taken to investigate the regulation of expression of succinate dehydrogenase (SDH) in S. meliloti. The sdhCDAB genes encoding SDH were shown by RT-PCR to be co-transcribed and thus constitute an operon. The transcriptional start site and putative promoter region of the first gene in the operon, sdhC , were identified by 5'-RACE and DNA sequence analysis. Transcriptional lacZ fusions to sdhC indicated that expression of the operon is regulated by carbon source in the growth medium but not by growth phase. The highest expression of the sdh operon was observed in cells grown with acetate, arabinose and glutamate, as sole carbon sources, and the lowest expression was observed in cells grown with glucose and pyruvate as sole carbon sources. / Also presented is the isolation and characterization of the first defined sdh mutant in a rhizobial species. The mutants helped demonstrate that the total lack of SDH activity would be lethal to S. meliloti cells. Symbiotic phenotype of the mutants indicated that SDH is required for N2-fixation.

In the N2 fixing legume symbiosis, mineral nitrogen (N) not only decreases N2 fixation, but also delays and inhibits the formation and development of nodules. The purposes of this thesis were to elucidate the role of signaling in the mineral N effects on nodulation and nitrogen fixation in soybean [Glycine max (L.) Merr.] and to attempt to find ways to overcome this inhibition. The responses of soybean plants, in terms of daidzein and genistein synthesis and exudation, to different mineral N levels were studied. Daidzein and genistein distribution patterns varied with plant organs, mineral N levels, and plant development stages. Mineral N inhibited daidzein and genistein contents and concentrations in soybean root and shoot extracts, but did not affect root daidzein and genistein excretion in the same way. In both synthesis and excretion, daidzein and genistein were not affected equally by mineral N treatments. Variability existed among soybean cultivars in the responses of root daidzein and genistein contents and concentrations to mineral N levels. The amount of daidzein and genistein excreted by soybean roots did not always correspond to the daidzein and genistein contents and concentrations inside the roots. On the Bradyrhizobium japonicum side, nod gene expression was inhibited by mineral nitrogen. Genistein was used to pre-incubate B. japonicum cells or was applied directly into the plant growing medium. The results showed that genistein manipulation increased nodule weight and nodule nitrogen fixation under greenhouse conditions, but interactions existed among soybean cultivars, genistein concentrations and nitrate levels. Similar results were found under field conditions. Soybean yield was increased on sandy-loam soil by preincubation of B. japonicum cells with genistein. Addition of genistein beginning at the onset of nitrogen fixation also improved soybean nodulation and nitrogen fixation. Soybean cultivars had different sensitivities to genistein additi / Other studies also show that temperature affected genistein and daidzein content and concentration in soybean roots. The effect of temperature varied among soybean cultivars. Some PGPR strains can mitigate the negative effects of nitrate on soybean nodulation and nitrogen fixation, however, this is influenced by soybean genotype. Applying PGPR together with genistein preincubation of B. japonicum cells improved soybean nodulation and increased yield. The level of improvement varied among soybean cultivars and PGPR strains. Preincubation of B. japonicum cells with genistein improved strain competitiveness under greenhouse, but not field conditions. / Overall, these findings suggested that both plant-to-Bradyrhizobium and Bradyrhizobium-to-plant signals play important roles in the effects of mineral N on nodulation and N fixation. Signal manipulation could partially overcome the inhibitory effects of mineral N on soybean- B. japonicum N fixation symbiosis.

Stat6 is a protein that activates the transcription of IL-4-stimulated genes. Amino acids critical for Stat6 function were examined in a mutational analysis of the Src homology (SH2) domain of the Stat6 protein. One mutation, substitution of two Alanines for Valine and Threonine in the N-terminal portion of the SH2 domain, produced a constitutively active form of the molecule that did not require IL-4 for activation. This mutant was named Stat6VT. Mice expressing Stat6VT in lymphocytes were generated, and it was found that approximately 10% of the population of Stat6VT mice, a lympho-proliferative disorder (LPD) occurred. In this study, we are examining genes that have a possible role in the development of this proliferative condition. Specifically, we examined the expression levels of Tiam1, Tacstdl, and Gfi-1 and Gfi-1B (genes known to regulate cellular proliferation and survival) in wildtype, normal Stat6VT and Stat6VT/LPD splenocytes by RT-PCR. Tiam1 results were inconclusive, and Tacstdl was not expressed at levels different from those seen in controls. Interestingly, Gfi-1 B, the homolog of Gfi-1, was expressed at increased levels in a specific subpopulation of cells from Stat6VT/LPD mice. Taken together, these data suggest that in cells expressing a constitutively active Stat6, increased expression of Gfi-1B may play a role in the mechanism of lymphoma development. / Department of Biology

Noonan syndrome (NS) is one of several autosomal dominant “RASopathies” caused by mutations in components of the RAS-RAF-MEK-ERK MAPK pathway. Germ line mutations in RAF1 (encoding the serine-threonine kinase for MEK1/2) account for ~3-5% of NS, and unlike other NS alleles, RAF1 mutations that confer increased kinase activity are highly associated with hypertrophic cardiomyopathy (HCM). Notably, some NS-associated RAF1 mutations show normal or decreased kinase activity. To explore the pathogenesis of such mutations, I generated “knock-in” mice that express kinase-activating (L613V) or -impaired (D486N) Raf1 mutants, respectively. Knock-in mice expressing the kinase-activated allele Raf1L613V developed typical NS features (short stature, facial dysmorphia, haematological abnormalities), as well as HCM. As expected, agonist-evoked Mek/Erk activation was enhanced in multiple cell types expressing Raf1L613V. Moreover, postnatal Mek inhibition normalized the growth, facial, and cardiac defects in L613V/+ mice, showing that enhanced Mek/Erk activation by Raf1 mutant is critical for evoking NS phenotypes. D486N/+ female mice exhibited a mild growth defect. Male and female D486N/D486N mice developed concentric cardiac hypertrophy and incompletely penetrant, but severe, growth defects. Remarkably, Mek/Erk activation was enhanced in Raf1D486N-expressing cells compared with controls. In both mouse and human cells, RAF1D486N, as well as other kinase-impaired RAF1 mutants, show increased heterodimerization with BRAF, which is necessary and sufficient to promote increased MEK/ERK activation. Furthermore, kinase-activating RAF1 mutants also require heterodimerization to enhance MEK/ERK activation. Our results suggest that increased heterodimerization ability is the common pathogenic mechanism for NS-associated RAF1 mutations.